Anebulo Pharmaceuticals, Inc. (ANEB)
$0.31-3.12%Close
SELLCRISIS · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $13M
- Beta
- -1.89
- P/E (TTM)
- -2.02
- Short % float
- 1.62%
- Days to cover
- 626.3
- SI change
- -0.1%
- 1W
- -3.13%
- 1M
- -13.89%
- vs SPY 1W
- -2.99%
- vs SPY 1M
- -16.39%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ANEB?
- LOPJLB’s latest quantitative signal on Anebulo Pharmaceuticals, Inc. (ANEB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ANEB in?
- Anebulo Pharmaceuticals, Inc. (ANEB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Anebulo Pharmaceuticals, Inc. (ANEB) do?
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The companyâs lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical …